EUVIMEDOpdag EUVIMED
Crossref

Hepatocytic lipocalin-2 controls HDL metabolism and atherosclerosis via Nedd4-1-SR-BI axis in mice

Shuwei Hu, Yingdong Zhu, Xiaojie Zhao, Rui Li, Guangze Shao, Dongxu Gong, Chencheng Hu, Hongjun Liu, Kexin Xu, Chenxi Liu, Minghuan Xu, Zhonghua Zhao and 8 more

Developmental Cell · 2023-11 · 58 (21) · 2326-2337.e5

DOI: 10.1016/j.devcel.2023.09.007 ↗

At a glance

Journal article in Developmental Cell, 2023-11. Written by Shuwei Hu and 19 co-authors. Institution: School of Basic Medical Sciences, Fudan University Shanghai, Shanghai 200032, China; Department of Integrative Medical Sciences, Northeast Ohio Medic…. Major MEDLINE topics: Lipoproteins, HDL, Atherosclerosis. Cited 22 times so far (Crossref); 44 references. Funded by: Foundation for Innovative Research Groups of the National Natural Science Foundation of China, National Natural Science Foundation of China, Beijing Municipal Natural Science Foundation.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

High-density lipoprotein (HDL) metabolism is regulated by complex interplay between the scavenger receptor group B type 1 (SR-BI) and multiple signaling molecules in the liver. Here, we show that lipocalin-2 (Lcn2) is a key regulator of hepatic SR-BI, HDL metabolism, and atherosclerosis. Overexpression of human Lcn2 in hepatocytes attenuates the development of atherosclerosis via SR-BI in western-diet-fed Ldlr-/- mice, whereas hepatocyte-specific ablation of Lcn2 has the opposite effect. Mechanistically, hepatocyte Lcn2 improves HDL metabolism and alleviates atherogenesis by blocking Nedd4-1-mediated SR-BI ubiquitination at K500 and K508. The Lcn2-improved HDL metabolism is abolished in mice with hepatocyte-specific Nedd4-1 or SR-BI deletion and in SR-BI (K500A/K508A) mutation mice. This study identifies a regulatory axis from Lcn2 to HDL via blocking Nedd4-1-mediated SR-BI ubiquitination and demonstrates that hepatocyte Lcn2 may be a promising target to improve HDL metabolism to treat atherosclerotic cardiovascular diseases.

Subjects

MeSH terms (MEDLINE)

Lipoproteins, HDLAtherosclerosisMiceHumansAnimalsLipocalin-2HepatocytesLiverCD36 Antigens

Author keywords

HDL metabolismLcn2SR-BI ubiquitinationatherosclerosis

Substances

Lipoproteins, HDLLipocalin-2CD36 Antigens

Authors and institutions

  • School of Basic Medical Sciences, Fudan University Shanghai, Shanghai 200032, China; Department of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH 44272, USA.
  • Department of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH 44272, USA.
  • Department of Pathology, School of Basic Medical Sciences, Fudan University Shanghai, Shanghai 200032, China.
  • Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.
  • Department of Hepatobiliary Surgery, Peking University People's Hospital Xizhimen South Street, West District, Beijing 100044, China.
  • Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210023, China.

Funding

  • Foundation for Innovative Research Groups of the National Natural Science Foundation of China
  • National Natural Science Foundation of China
  • Beijing Municipal Natural Science Foundation

Cite

APA

Hu, S., Zhu, Y., Zhao, X., Li, R., Shao, G., Gong, D., Hu, C., Liu, H., Xu, K., Liu, C., Xu, M., Zhao, Z., Li, T., Hu, Z., Shao, M., Liu, J., Li, X., Wu, H., Li, J., & Xu, Y. (2023). Hepatocytic lipocalin-2 controls HDL metabolism and atherosclerosis via Nedd4-1-SR-BI axis in mice. Developmental Cell, 58(21), 2326-2337.e5. https://doi.org/10.1016/j.devcel.2023.09.007

Vancouver

Hu S, Zhu Y, Zhao X, Li R, Shao G, Gong D, et al. Hepatocytic lipocalin-2 controls HDL metabolism and atherosclerosis via Nedd4-1-SR-BI axis in mice. Developmental Cell. 2023;58(21):2326-2337.e5. doi:10.1016/j.devcel.2023.09.007

BibTeX
@article{Hu2023,
  author = {Hu, Shuwei and Zhu, Yingdong and Zhao, Xiaojie and Li, Rui and Shao, Guangze and Gong, Dongxu and Hu, Chencheng and Liu, Hongjun and Xu, Kexin and Liu, Chenxi and Xu, Minghuan and Zhao, Zhonghua and Li, Tao and Hu, Zhigang and Shao, Mengle and Liu, Jun- and Li, Xinwei and Wu, Huijuan and Li, Jing and Xu, Yanyong},
  title = {Hepatocytic lipocalin-2 controls HDL metabolism and atherosclerosis via Nedd4-1-SR-BI axis in mice},
  journal = {Developmental Cell},
  year = {2023},
  volume = {58},
  number = {21},
  pages = {2326--2337.e5},
  doi = {10.1016/j.devcel.2023.09.007}
}
Start for free →